Skip to main content

Table 3 Associated factors with malignant IPMNs

From: The association between serum ferritin levels and malignant intraductal papillary mucinous neoplasms

 

A

   

B

 

variables

Univariable

Multivariable

  

Multivariable

 
 

Model 1

Model 2

Model3

Model 1

Model 2

OR (95%CI)

OR (95%CI)

OR (95%CI)

OR (95%CI)

OR (95%CI)

OR (95%CI)

Age

0.99(0.95–1.03)

0.97(0.93–1.02)

0.98(0.93–1.02)

0.97(0.93–1.02)

0.97(0.93–1.02)

0.97(0.93–1.02)

Sex

0.54(0.26–1.15)

0.57(0.24–1.38)

0.56(0.23–1.37)

0.56(0.23–1.36)

0.84(0.33–2.18)

0.83(0.32–2.15)

Size (cm)

1.09(0.91–1.30)

1.06(0.87–1.29)

1.05(0.86–1.28)

1.04(0.85–1.27)

1.07(0.87–1.31)

1.06(0.87–1.30)

Type

 Main-duct

1

1

1

1

1

1

 Branch-duct

0.07(0.02–0.21)

0.06 (0.02–0.21)

0.06 (0.02–0.20)

0.06 (0.02–0.21)

0.08 (0.02–0.27)

0.08 (0.02–0.28)

 Mixed

0.34(0.13–0.94)

0.36(0.12–1.07)

0.34(0.11–1.04)

0.35(0.12–1.08)

0.39(0.13–1.24)

0.41(0.13–1.28)

Location

 Head-neck

1

1

1

1

1

1

 Body-Tail

0.54(0.26–1.15)

0.61(0.24–1.52)

0.51(0.19–1.37)

0.53(0.19–1.43)

0.44(0.16–1.21)

0.47(0.17–1.28)

Ferritin (×100, ng/ml)

Ferritin (> 149 vs ≤ 149 ng/ml)

1.19(1.04–1.35)

1.19(1.02–1.39)

1.19(1.02–1.39)

1.18(1.01–1.39)

5.70(1.80–18.11)

5.64(1.78–17.92)

  1. A: Serum ferritin was continuous variable; Model 2 was adjusted with pancreatitis and chronic cholecystitis; Model 3 was additionally adjusted with diabetes
  2. B: Serum ferritin was categorical variable; Model 1 was adjusted with pancreatitis and chronic cholecystitis; Model 2 was additionally adjusted with diabetes
  3. CI confidence interval; OR odds ratio